Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,179 | -5,732 | -3,352 | -16,058 | -13,220 |
| Depreciation Amortization | 28 | 19 | 10 | 17,631 | 14,065 |
| Income taxes - deferred | N/A | N/A | 0 | -1,612 | -1,342 |
| Accounts payable and accrued liabilities | 96 | 1,838 | 198 | 6,207 | 4,483 |
| Other Working Capital | -126 | 1,690 | 571 | -328 | -1,259 |
| Other Operating Activity | -892 | -3,512 | -628 | -22,657 | -17,098 |
| Operating Cash Flow | $-11,073 | $-5,697 | $-3,201 | $-16,817 | $-14,371 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -18 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 809 | 809 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $791 | $809 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,050 | N/A | 1,000 | N/A |
| Debt Repayment | -3,698 | -3,348 | N/A | N/A | N/A |
| Common Stock Issued | 18,615 | 6,815 | N/A | N/A | N/A |
| Other Financing Activity | -4,444 | -494 | 1,158 | -2,311 | -2,311 |
| Financing Cash Flow | $10,473 | $4,023 | $1,158 | $-1,311 | $-2,311 |
| Exchange Rate Effect | -30 | 65 | 309 | -189 | 264 |
| Beginning Cash Position | 2,029 | 2,029 | 2,029 | 19,555 | 19,555 |
| End Cash Position | 1,399 | 420 | 295 | 2,029 | 3,946 |
| Net Cash Flow | $-630 | $-1,609 | $-1,734 | $-17,526 | $-15,609 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,073 | -5,697 | -3,201 | -16,817 | -14,371 |
| Capital Expenditure | N/A | N/A | N/A | -18 | N/A |
| Free Cash Flow | -11,073 | -5,697 | -3,201 | -16,835 | -14,371 |